In May 2018, a class-action lawsuit was filed against SanMedica International for allegedly falsely advertising the Human Growth Hormone (HGH) supplement SeroVital-hgh. Specifically, plaintiffs claim that SanMedica falsely markets the…
April 2017: The Ninth Circuit Court of Appeals affirmed the district court’s decision to dismiss this lawsuit. March 2015: The plaintiffs appealed the district court’s decision to dismiss the lawsuit.…
In Oct 2016, a class-action lawsuit was filed against Sanmedica International for allegedly falsely advertising that Sero Vital-hgh provides anti-aging benefits. Specifically, the complaint alleges that the company markets the…